Craig Kutz
Affiliations: | 2012-2015 | Drug Discovery and Biomedical Sciences | Medical University of South Carolina, Charleston, SC, United States |
Google:
"Craig Kutz"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nowotarski SL, Pachaiyappan B, Holshouser SL, et al. (2018) Corrigendum to "Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures" [Bioorg. Med. Chem. 23 (2015) 1601-1612]. Bioorganic & Medicinal Chemistry |
| Nowotarski SL, Pachaiyappan B, Holshouser SL, et al. (2015) Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures. Bioorganic & Medicinal Chemistry. 23: 1601-12 |
| Cafiero RM, Holshouser S, Kutz C, et al. (2015) Novel Epigenetic Modulators That Promote Fetal Hemoglobin Production for the Prevention of Sickle Cell Disease Related Complications Blood. 126: 973-973 |
| Kutz CJ, Holshouser SL, Marrow EA, et al. (2014) 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors. Medchemcomm. 5: 1863-1870 |
| Kutz CJ, Holshouser SL, Marrow EA, et al. (2014) 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors Medchemcomm. 5: 1863-1870 |